Literature DB >> 9426975

Production of activin A and its roles in inflammation and hematopoiesis.

J Yu1, K E Dolter.   

Abstract

Activin A, a member of the transforming growth factor beta (TGF-beta) superfamily, is a protein consisting of two homodimeric beta A subunits. It was originally isolated from follicular fluid as a factor stimulating the release of follicle-stimulating hormone from the pituitary gland. Increasing evidence suggests that activin A is broadly distributed and regulates multiple functions in various biological systems by autocrine/paracrine mechanisms. In this review, we discuss the effects of activin A on hematopoiesis, especially the enhancement of erythropoiesis, and the production of activin A within the bone marrow microenvironment and in peripheral blood monocytes. The regulatory control of activin A expression by its 5' promoter region is also discussed. Furthermore, we consider that the expression of activin A is modulated by different agents, including proinflammatory cytokines, glucocorticoids and retinoic acid, suggesting new roles for activin A in inflammation reactions. Recently, this role in inflammation was further strengthened by the findings that activin A expression is elevated in inflammatory arthropathies, is regulated by inflammation-associated cytokines in synoviocyte and articular chondrocyte cultures, and is able to counteract many of the interleukin-6 (IL-6)-induced biological activities. Therefore it is likely that activin A may also act as a paracrine/autocrine moderator in diverse functions, including host defenses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426975

Source DB:  PubMed          Journal:  Cytokines Cell Mol Ther        ISSN: 1368-4736


  12 in total

1.  cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.

Authors:  B K Coombes; J B Mahony
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies.

Authors:  E W Yu; K E Dolter; L E Shao; J Yu
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A.

Authors:  R M Nüsing; J Barsig
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.

Authors:  Deh-Ming Chang; Shao-Hsiang Liu; Herng-Sheng Lee; Jenn-Hung Lai; Chen-Hung Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

5.  Rat activin-betaE mRNA expression during development and in acute and chronic liver injury.

Authors:  Elspeth J Gold; Marcel A Monaghan; Jean S Fleming
Journal:  J Mol Genet Med       Date:  2006-04-12

6.  Activin A expression regulates multipotency of mesenchymal progenitor cells.

Authors:  Farida Djouad; Wesley M Jackson; Brent E Bobick; Sasa Janjanin; Yingjie Song; George T J Huang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2010-05-04       Impact factor: 6.832

7.  Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells.

Authors:  Matthew B Reeves; Teresa Compton
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

8.  Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation.

Authors:  Pin Xu; Charles Van Slambrouck; Liliana Berti-Mattera; Alison K Hall
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

Review 9.  Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an overview.

Authors:  Rebecca S Y Wong
Journal:  Exp Diabetes Res       Date:  2011-06-16

10.  CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion.

Authors:  Grégoire F Le Bras; Gillian L Allison; Nicole F Richards; Shazia S Ansari; M Kay Washington; Claudia D Andl
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.